Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 8 , Pages 1002-1008 , August 2007

Quantitative and Clinical Description of Postural Instability in Women With Breast Cancer Treated With Taxane Chemotherapy

Presented, in part, to the American Physical Therapy Association Combined Sections meeting, February 1–5, 2006, San Diego, CA; the Supportive Oncology meeting, October 6–8, 2005, Chicago, IL; and the International Society of Posture and Gait Research XVIIth Conference, May 29–June 2, 2005, Marseille, France.

  • Meredith A. Wampler, PT, DPTSc

      Affiliations

    • Department of Rehabilitation, Harrison Medical Center, Bremerton, WA
    • Corresponding Author InformationReprint requests to Meredith A. Wampler, PT, DPTSc, Harrison Medical Center, Rehabilitation Services, 2520 Cherry Ave, Bremerton, WA 98310
    • ,
  • Kimberly S. Topp, PT, PhD

      Affiliations

    • Department of Physical Therapy and Rehabilitation Science, University of California School of Medicine, and Graduate Program in Physical Therapy, San Francisco State University, San Francisco, CA
    • ,
  • Christine Miaskowski, RN, PhD

      Affiliations

    • Department of Physiological Nursing, University of California School of Nursing, San Francisco, CA
    • ,
  • Nancy N. Byl, PT, PhD

      Affiliations

    • Department of Physical Therapy and Rehabilitation Science, University of California School of Medicine, and Graduate Program in Physical Therapy, San Francisco State University, San Francisco, CA
    • ,
  • Hope S. Rugo, MD

      Affiliations

    • School of Medicine, University of California, San Francisco, CA
    • ,
  • Kate Hamel, PhD

      Affiliations

    • Department of Kinesiology, San Francisco State University, San Francisco, CA.

References 

  1. American Cancer Society. Cancer facts and figures. Atlanta: ACS; 2007;
  2. Sartor CI, Peterson BL, Woolf S, et al. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. J Clin Oncol. 2005;23:30–40
  3. Martin M, Pienkowski T, Mackey J, et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med. 2005;352:2302–2313
  4. Docetaxel. Bridgewater: Aventis; 2004;[package insert]
  5. Paclitaxel. Princeton: Bristol Meyers Squibb; 2003;[package insert]
  6. Abraxane. Schaumburg: Abraxis; 2005;[package insert]
  7. Del Mastro L, Venturini M, Lionetto R, et al. Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol. 1997;15:2715–2721
  8. Holmes FA, O’Shaughnessy JA, Vukelja S, et al. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol. 2002;20:727–731
  9. Lindley C, Goodin S, McCune J, et al. Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone. Am J Clin Oncol. 2005;28:270–276
  10. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol. 1994;35:304–311
  11. Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol. 1997;35:47–53
  12. Lipton RB, Apfel SC, Dutcher JP, et al. Taxol produces a predominantly sensory neuropathy. Neurology. 1989;39:368–373
  13. New PZ, Jackson CE, Rinaldi D, Burris H, Barohn RJ. Peripheral neuropathy secondary to docetaxel (Taxotere). Neurology. 1996;46:108–111
  14. van Gerven JM, Moll JW, van den Bent MJ, et al. Paclitaxel (Taxol) induces cumulative mild neurotoxicity. Eur J Cancer. 1994;30A:1074–1077
  15. Wampler MA, Miaskowski C, Hamel K, Byl NB, Rugo H, Topp KS. The Modified Total Neuropathy Score: a clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer. J Support Oncol. 2006;4:397–402
  16. Nardone A, Grasso M, Schieppati M. Balance control in peripheral neuropathy: are patients equally unstable under static and dynamic conditions?. Gait Posture. 2006;23:364–373
  17. Corriveau H, Prince F, Hebert R, et al. Evaluation of postural stability in elderly with diabetic neuropathy. Diabetes Care. 2000;23:1187–1191
  18. Horak FB, Dickstein R, Peterka RJ. Diabetic neuropathy and surface sway-referencing disrupt somatosensory information for postural stability in stance. Somatosens Mot Res. 2002;19:316–326
  19. Menz HB, Lord SR. Foot pain impairs balance and functional ability in community-dwelling older people. J Am Podiatr Med Assoc. 2001;91:222–229
  20. Simoneau GG, Ulbrecht JS, Derr JA, Becker MB, Cavanagh PR. Postural instability in patients with diabetic sensory neuropathy. Diabetes Care. 1994;17:1411–1421
  21. Richardson JK. Factors associated with falls in older patients with diffuse polyneuropathy. J Am Geriatr Soc. 2002;50:1767–1773
  22. Thies SB, Richardson JK, Demott T, Ashton-Miller JA. Influence of an irregular surface and low light on the step variability of patients with peripheral neuropathy during level gait. Gait Posture. 2005;22:40–45
  23. Richardson JK, Thies SB, DeMott TK, Ashton-Miller JA. Gait analysis in a challenging environment differentiates between fallers and nonfallers among older patients with peripheral neuropathy. Arch Phys Med Rehabil. 2005;86:1539–1544
  24. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain. 2004;109:132–142
  25. Messier SP, Glasser JL, Ettinger WH, Craven TE, Miller ME. Declines in strength and balance in older adults with chronic knee pain: a 30-month longitudinal, observational study. Arthritis Rheum. 2002;47:141–148
  26. Corriveau H, Hebert R, Prince F, Raiche M. Postural control in the elderly: an analysis of test-retest and interrater reliability of the COP-COM variable. Arch Phys Med Rehabil. 2001;82:80–85
  27. Gill-Body KM, Beninato M, Krebs DE. Relationship among balance impairments, functional performance, and disability in people with peripheral vestibular hypofunction. Phys Ther. 2000;80:748–758
  28. Lord SR, Clark RD, Webster IW. Visual acuity and contrast sensitivity in relation to falls in an elderly population. Age Ageing. 1991;20:175–181
  29. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53:740–745
  30. Nashner LM, Peters JF. Dynamic posturography in the diagnosis and management of dizziness and balance disorders. Neurol Clin. 1990;8:331–349
  31. Ford-Smith CD, Wyman JF, Elswick RK, Fernandez T, Newton RA. Test-retest reliability of the sensory organization test in noninstitutionalized older adults. Arch Phys Med Rehabil. 1995;76:77–81
  32. Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test. Arch Phys Med Rehabil. 1986;67:387–389
  33. Karlsson A, Frykberg G. Correlations between force plate measures for assessment of balance. Clin Biomech (Bristol, Avon). 2000;15:365–369
  34. Rose DJ. Fall Proof!: a comprehensive balance and mobility training program. Champaign: Human Kinetics; 2003;
  35. Portney LG, Watkins MP. Foundations of clinical research. 2nd ed.. Upper Saddle River: Prentice Hall Health; 2000;
  36. Di Nardo W, Ghirlanda G, Cercone S, et al. The use of dynamic posturography to detect neurosensorial disorder in IDDM without clinical neuropathy. J Diabetes Complications. 1999;13:79–85
  37. Doxorubicin. Kalamazoo: Pharmacia and Upjohn; 2000;[package insert]
  38. Cyclophosphamide. Princeton: Bristol-Myers Squibb; 2000;[package insert]
  39. Scaioli V, Caraceni A, Martini C, Curzi S, Capri G, Luca G. Electrophysiological evaluation of visual pathways in paclitaxel-treated patients. J Neurooncol. 2006;77:79–87
  40. Tan WW, Walsh T. Ocular toxicity secondary to paclitaxel in two lung cancer patients. Med Pediatr Oncol. 1998;31:177
  41. Kende G, Sirkin SR, Thomas PR, Freeman AI. Blurring of vision: a previously undescribed complication of cyclophosphamide therapy. Cancer. 1979;44:69–71
  42. Griffin JD, Garnick MB. Eye toxicity of cancer chemotherapy: a review of the literature. Cancer. 1981;48:1539–1549
  43. Socie G, Clift RA, Blaise D, et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood. 2001;98:3569–3574
  44. Sergi B, Ferraresi A, Troiani D, Paludetti G, Fetoni AR. Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hear Res. 2003;182:56–64
  45. Peterka RJ, Loughlin PJ. Dynamic regulation of sensorimotor integration in human postural control. J Neurophysiol. 2004;91:410–423

 Supported by the California Breast Cancer Research Program, dissertation award (grant no. 10GB-0001).

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(07)00350-4

doi: 10.1016/j.apmr.2007.05.007

Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 8 , Pages 1002-1008 , August 2007

Article Tools

* Image Usage & Resolution